SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Concentrix Corporation (CNXC) has a negative trailing P/E of -1.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 2.4 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -77.46%, forward earnings yield 41.32%. PEG 0.27 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.27); analyst target implies upside (+83.9%).
- Forward P/E 2.4 — analysts expect a return to profitability with estimated EPS of $11.71 for FY2026.
- PEG Ratio 0.27 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield -77.46% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 41.32% as earnings recover.
- Analyst consensus target $52.00 (+83.9% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 56/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CNXC
Valuation Multiples
P/E (TTM)-1.3
Forward P/E2.4
PEG Ratio0.27
Forward PEG0.27
P/B Ratio0.61
P/S Ratio0.17
EV/EBITDA-6.6
Per Share Data
EPS (TTM)$-21.66
Forward EPS (Est.)$11.71
Book Value / Share$45.50
Revenue / Share$162.44
FCF / Share$7.91
Yields & Fair Value
Earnings Yield-77.46%
Forward Earnings Yield41.32%
Dividend Yield4.95%
SharesGrow IV$272.44 (+863.4%)
Analyst Target$52.00 (+83.9%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2017 |
57.2 |
0.00 |
0.00 |
2.08 |
- |
| 2018 |
85.5 |
-2.60 |
3.13 |
1.68 |
- |
| 2019 |
35.2 |
0.25 |
2.81 |
0.88 |
- |
| 2020 |
25.0 |
0.62 |
1.79 |
0.87 |
- |
| 2021 |
21.0 |
0.15 |
3.25 |
1.53 |
0.15% |
| 2022 |
14.4 |
2.01 |
2.33 |
0.99 |
0.85% |
| 2023 |
16.1 |
-0.51 |
1.22 |
0.71 |
1.26% |
| 2024 |
11.6 |
-0.33 |
0.72 |
0.30 |
2.87% |
| 2025 |
-1.8 |
0.00 |
0.84 |
0.23 |
3.89% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$1.40 |
$1.99B |
$72.25M |
3.6% |
| 2018 |
$0.93 |
$2.46B |
$48.27M |
2% |
| 2019 |
$2.27 |
$4.71B |
$117.16M |
2.5% |
| 2020 |
$3.19 |
$4.72B |
$164.81M |
3.5% |
| 2021 |
$7.70 |
$5.59B |
$405.58M |
7.3% |
| 2022 |
$8.28 |
$6.32B |
$435.05M |
6.9% |
| 2023 |
$5.70 |
$7.11B |
$313.84M |
4.4% |
| 2024 |
$3.71 |
$9.62B |
$251.22M |
2.6% |
| 2025 |
$-20.36 |
$9.83B |
$-1.28B |
-13% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$11.71 |
$11.57 – $11.84 |
$10.11B |
$10.05B – $10.17B |
3 |
| 2027 |
$12.84 |
$12.64 – $13.03 |
$10.36B |
$10.3B – $10.43B |
3 |
| 2028 |
$15.32 |
$15.21 – $15.44 |
$10.79B |
$10.73B – $10.86B |
2 |
| 2029 |
$15.19 |
$15.07 – $15.31 |
$10.86B |
$10.8B – $10.92B |
1 |
